In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors by unknown
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Normally, exposure of an adult animal to novel antigen produces immunological
priming . However, intravenous injection of allogeneic cells can result in specific in-
hibition (1-9) . Thus, lymphoid cells from amouse previously injected intravenously
with viable allogeneic lymphocytes willmount a greatly reducedCTL response against
cells identical to the injected cells, but not against unrelated cells, when cultured
inan in vitroMLR (2, 5-8) . The reduction in the ability of an injected host to mount
a cytolytic response against the donor is very rapid, being detectable after <1 d,
maximal at 2 d, and still detectable at 11 wk . By injecting fluorochrome-labeled donor
cellswe have been able to separate the residentdonor cells from recipient cells before
analysis of function in vitro. Using this technique, and the techniques of limiting
dilution analysis of mixed responder cell populations, we have shown that the re-
sponse reduction seen up to 8 d after injection ofdonor cells is due to functional
deletion of CTL precursors (CTLp) 1 in vivo (6-8), rather than activation of sup-
pressor cells of either host or donor origin (10-13) that mediate their effect in vitro,
or redistribution of cells from lymph nodes to spleen within the recipient (14-16) .
We further show that donor cells can be recovered from a first recipient and used
to induce response reduction in a second recipient . The observations are discussed
with respect to the phenomenon of veto (17-20).
Materials and Methods
Mice. Male C57BL/6J (B6), DBA/2J (D2), (C57BL/6J x DBA/2J)F, (BDF,), and
B10.BR (BR) mice were obtained from TheJackson Laboratories (Bar Harbor, ME) . Their
H-2 haplotypes correspond to b,d, b/d, and k respectively . All mice arrived at our animal
facility at 6 wk of age, and were subsequently used between 7 and 10 wk of age .
Preparation and Injection ofthe Donor Cells.
￿
Lymph node cells(LNC) were isolated from the
superficial and deep cervical, inguinal, and mesenteric lymph nodes . Lymph nodes were placed
inmedium (aMEM with 10% FCS, 50AM 2-ME, and 10mM Hepes) atroom temperature
and teased apart by gently squeezing them through a wire mesh with a disposable syringe
plunger. Released cells (in 6 ml) were layered over 3 ml of6% BSA in PBS, centrifuged to
separate lymphocytes from adipocytes, resuspended in 5 ml ofmedium, then underlayed with
5 ml Lympholyte-M (Cederlane, Laboratories, Hornby, Ontario), and centrifuged at room
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temperature for 20 min at 400 g to remove fine debris, erythrocytes, and dead cells . After
washing with PBS containing I% FCS (PBS I% FCS), the LNG were adjusted to 25 x 106
cells/ml and 0.4 ml of this suspension was injected into the lateral tail vein of a recipient
mouse . At this point, the LNC viability was typically >96% .
Labeling Donor Cells withFIX.
￿
Generally following Butcher and Weissman (21), cells pre-
pared as above were resuspended to a concentration of 50 x 10 6 cells/ml of 0.9% BSA in
PBS and aFITC stock solution (600 tug/ml in PBS) was added to make a final concentration
of 30 gg/ml. After a 20-min incubation at 37'C in a water bath placed in an incubator with
a 10% C02/air atmosphere, the reaction was stopped by addition of 5 ml medium and cen-
trifugation through 3 ml of 6% BSA in PBS, followed by washing with PBS 1% FCS .
Analysis and Separation of Donor Cells Retrievedfrom the Recipient.
￿
LNC were isolated from
recipients of an injection of 1-2 x 10' FITC-labeled cells. The labeled cells were identified
and could be sorted apart from the host cells using a Coulter EpicsV flow cytometer. Dead
cells were eliminated based on forward angle light scatter and analysis was typically based
on 3 x 10 4 to 1 x 105 events . Flow cytometric analysis of labeled populations showed that
100% of the cells were initially brightly labeled .
The magnitude of fluorescence ofcells, retrieved from lymph nodes or spleens of intrave-
nously injected mice, though remaining bright and easily detectable, decreased rapidly during
the first few hours, then remained relatively constant, decreasing very slowly over the fol-
lowing days (N5-10% per day). Examination oflabeled cells by fluorescence microscopy showed
a correlation between the rapid loss offluorescence and an altered pattern ofstaining, which
changed from bright rim fluorescence to a diffuse cytosolic fluorescence that included the
nucleus ofall cells (although initially fluorescence is absent in the nuclei) . In vitro cell mixing
experiments between labeled and unlabeled cell populations showed no evidence for transfer
of label between neighboring cells, supporting earlier in vivo findings by others (22) .
Generation ofCTL and the Cytotoxicity Assay.
￿
A standard MLR was used to activate and ex-
pand reactive CTL within the responder LNC population . 3 x 10 4 responder B6 LNC were
cultured for 5 d with 3 x 105 BDF, irradiated (2,000 rad) spleen cells in 96-well V-bottomed
plates (Linbro; Flow Laboratories, Mississauga, Ontario), six replicates per group, then tested
for the ability to kill "Cr-labeled BDF 1 or D2 spleen cell ConA blasts, or "Cr-labeled P815
(H-2d) tumor targets, as previously described (23) . The specific cytolytic activity (23) of the
experimental group was expressed as a fraction of the control (mean t 1 SD) within each
experiment . The control response was determined usingLNC responder cells isolated from
identically treated mice that had received 10' fully syngeneic LNC in place of donor BDF,
cells . The response against third-partyBR was tested in each experiment to verify the specificity
of a reduced response.
Limiting Dilution Analysis.
￿
The CTLp frequency within responder LNC populations was
determined by limiting dilution analysis as previously described (23) . Briefly, 100, 300, 600,
1,000, or 3,000 responder cells were distributed into 30, 24, 24, 18, or 12 wells, respectively,
in 96-well Vbottomed plates. Additionally, each well received 3 x 105 irradiated spleen cells,
as stimulators, and an optimal concentration of growth and differentiation factors, typically
10% rat ConA supernatant containing 45 mM a-methyl mannoside. After 5 d of culture,
3,000 BDF,, D2, or BR "Cr-labeled spleen cellCon A blast targets were added to each well .
The spontaneous release ranged from 11 to 15% oftotal releasable radioactivity. This method
has been previously characterized as having the sensitivity to detect the killing of a clonal
population of CTL, that have expanded from a single CTLp (23) . Each well was scored as
either plus (having lyric activity) or minus (not having lyric activity), and a fit to single hit
limiting dilution was tested . Subsequently, the relative frequency ofCTLp in the experimental
LNC population wascalculated as afraction ofthe frequency ofCTLp in the control populati
Results
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￿
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FIGURE 1 .
￿
Cytolytic activity ofB6LNC against
BDFI spleen cells in a 5-dMLR. The response
by cells taken from B6 mice at various times after
the injection of 107 BDFI LNC is shown as a
fraction of the response by cells takenfrom con-
trol B6 mice simultaneously injected with 107B6
LNC .
reduction of the response was detected by 24 h after the injection, approached a
maximal levelby 48 h, and persisted for at least 11 wk . The response of the injected
mice against third-party cells, from BR or C3H, was not altered (e.g ., see Fig. 2) .
Thus, the reduction of the response was specific for thoseT cells carrying receptors
that were reactive with allogeneic determinants carried on the surface ofthe injected
BDFI lymph node cells. Note that FI cells were used as donor cells to avoid the
potential complications of a graft-vs.-host reaction .
Analysis of the Fate of the Injected Cell Population.
￿
We sought a method to identify
and, ifdesired, remove the injected FI cells before in vitro testing . It has been shown
previously (22) that FITC-conjugated lymphoid cells appear to remain labeled and
to recirculatenormallywhen injected intravenously into mice .Wefoundthat FITC
conjugation of BDFI cells did not alter their ability to specifically reduce the sub-
sequent response of B6 recipients against D2 alloantigen (Fig . 2) .
Fig . 3 shows two-dimensional profiles offorward angle light scatter versus fluores-
cence intensity for lymph node cells from B6 mice injected 2 d previously with 10'
FIGURE 2.
￿
Priorconjugation ofFITC
to BDFI donor LNC does not alter
the capacity to reduce the B6 anti
BDFI response. B6 recipients were ei-
ther not injected (i.e ., unmanipulated
control) or injected with 10 1 unlabeled
LNCor 10 7 FITC-labeled LNC from
the indicated donors. The relative re-
sponse to a third-party alloantigen(anti
BlO.BRresponse) is shown in the right
half of the figure .
FIGURE 3 .
￿
Two-dimensional profiles
offorward angle light scatterversus rel-
ative fluorescence intensity of 10 5
LNC from B6 mice injected 2 d previ-
ously with either 10 7 B6-FITC (a), or
BDFI-FITC (b) LNC . The data are
presented as contours, the number
shown within a contour line corre-
sponding to loge ofthenumber ofcells
counted at that level . The B6-FITC
cells comprised 1.8%, while theBDFI-
FITC comprised 1.7% of the total
number of cells analyzed.682 HISTOINCOMPATIBLE LYMPHOCYTES IN CTL PRECURSOR DELETION
FITC-conjugated B6 or BDFI lymph node cells. The injected cells can be readily
distinguished from host cells . Note that there are no obvious differences in the dis-
tributions observed in mice injected with fluorescent BDFI or B6 (self) lymph node
cells . As a function oftime after injection, the fraction of FITC-labeled cells (either
BDFI-FITC or B6-FITC) approached the same steady-state value in both lymph
node and spleen, varyingfrom an average of 1.3-1.9% after 24 h in different experi-
ments (Fig . 4), and remained constant for over 5 d. The results are numerically
consistent with the proposition that the injected cells have homogeneously mixed
with the host recirculating lymphocyte pool . This proposition is further supported
by the observation that doubling the number of injected cells resulted in doubling
the fraction appearing in the lymphoid tissues (data not shown) .
Response Reduction in Lymph Node and Spleen.
￿
Previous results (2) indicated that
intravenous injection of viable semiallogeneic Fi lymphoid cells reduced the re-
sponse ofboth lymph node and spleen cells against the injected alloantigen in asub-
sequent in vitro MLR. To make a more quantitative comparison, in this study we
measured the response reduction in a defined population of host cells capable of
reaching lymph nodes and spleen after intravenous injection : 10' FITC-labeled
lymph node cells from B6 donors were injected into syngeneic B6 recipients, fol-
lowed 24 h later by 10' unlabeled BDFI cells. Lymph node and spleen cells were
prepared 5 d afterthe first injection and the B6-FITC cellswere separatedbyFAGS .
When tested for their ability to respond in theMLR, the recovered B6-FITC cells
from either lymph nodes or spleen showed equally reduced responses against BDFI
stimulator cells but normal responses against BR (Fig . 5) . These results imply that
the response capability of alllymphocytes in the recirculatingpool is equally reduced .
Mechanism of Response Reduction.
￿
The population oflymph node cells taken from
an injected animal includes injected FI cells. It is possible that these cells, either
directly or indirectly, induce suppression during the in vitro culture period . To ad-
dress this question, BDFI-FITC cells were injected into the parent at various time
intervals before removing the lymph nodes, and before culture, labeled cells were
removed by cell sorting . The results (Fig. 6) indicate that removal of the injected
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FIGURE 4 .
￿
The fraction of recipient LNC comprised
of donor cells, as a function oftime after injection. B6
recipients received either 10' B6-FITC LNC (closed
circles), or 10' BDFI LNC (open circles) . This analysis was
performed by fluorescence flow cytometry. Each point
represents results accumulated from two to five inde-
pendent groups of experiments, and is expressed as a
mean t I SD.BDFI-FITC cells from the responder population did not alter the magnitude of the
reduction detected in theMLR. Note that reanalysis of the sorted cellsdemonstrated
that the fluorescent donor cells were typically reduced to 0.01% or less of the total
population, indicating that no more than three fluorescent donor cells were added
to each MLR (see Materials and Methods) .
We have considered three possible explanations forthe above results : (a) Suppressor
cells of recipient origin became activated in vivo andmediated suppression in vitro;
(b) suppressor cells of donor (Ft) origin became activated in vivo, in the process
losing their fluorescent label, and mediated suppression in vitro; (c) recipientCTL
precursors became inactivated in vivo before the cells were placed in theMLR. To
distinguish among these possibilities, we used limiting dilution analysis to measure
the frequency of CTLp reactive to BDFI cells in BDFt-injected and control B6-in-
jected mice. Fig . 7 shows that the reduction in the magnitude of theMLR response
in Fl-injected mice at varying times after injection was reflected by an equivalent,
proportional decrease in theCTLp frequency . This suggests that response reduc-
tion is entirely the result of functional deletion ofCTLp in vivo and not due to the
induction of suppressor cells of either recipient or donor origin in vitro.
As a further test for the presence of suppressor cells acting in vitro, we measured
the frequency ofCTLp in an equal mixture of cells from control and Fl-injected
mice on the assumption that any suppressor cells present should have an effect on
theCTLp of both populations . The measured CTLp frequency was equivalent to
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￿
The responses of lymphocytes recirculating through
lymphnode and spleen are reduced equally byexposure to semi-
allogeneic cells . FITC-labeled B6 LNCwere injected intrave-
nously into syngeneic B6 recipients (day -5) . One day later
(day -4), the mice were further injected with either 107BDF,
or 107 B6 LNC . 4 d later (day 0), FITC-labeled cells were re-
covered by cell sorting from both lymph node and spleen of
each group and tested for their ability to generate CTL as in-
dicated . Reanalysis of 104 sorted cells indicatedan enrichment
to 92-96% fluorescence positive cells for LNC, and 76-78%
for spleen cells.
FIGURE 6.
￿
Removal ofthe FITC-labeled
resident BDFI LNG from the B6 re-
sponder cell population before theMLR
does not reverse reductionofcytolytic ac-
tivity.684 HISTOINCOMPATIBLE LYMPHOCYTES IN CTL PRECURSOR DELETION
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FIGURE 7.
￿
The relative degree of reduction in the MLR (a) is reflected by a similar decrease
in the relative frequencyof CTLp, as determined from limiting dilution analysis (b). Each symbol
refers to adifferent experimental group of animals. Each point is derived from the analysis of
theresponse of two to four mice. B6 mice were injected with 107 BDFI LNC, then killed after
the indicated interval of time. Points labeled 0 + 4 day, 0 + 5 day, and 0 + 8 day indicate
therelative frequency of CTLp measured in responder LNC taken from control strain A mice
mixed in a 1:1 ratiowith responder LNC taken from mice killed 4, 5, or 8 d after the injection
of BDFI cells. The arrows indicate the predicted relative frequencies determined by calculating
themathematical mean ofthe individually measured frquencies. The rangeofCTLp frequency
reactive to BDFI in the controlpopulations was 1/330to 1/445. Thedecrease in CTLp frequency
was specific since the frequencies of CTLp reactive to an unrelated third party did not vary
significantly between experimental and control populations (data not shown).
the predicted mean of the CTLp frequencies determined foreach population mea-
sured separately (right side, Fig. 7 b), suggesting no suppressor cells were present.
FI Cells Recoveredfrom a First Recipient Can Induce Response Reduction in a Second Re-
cipient.
￿
We next asked whether cells from a first B6 recipient injected with FITC-
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TABLE I
Ability of Host or Recovered Donor Cells to Induce Response Reduction
When Reinjected into New Recipients
B6 mice were injected with 1 .5 x 107 BDFI-FITC LNC. 6 d later, LNC were collected and injected in
the numbers indicated into secondary B6 recipients either after sorting into labeled and unlabeled fractions
or unsorted. LNC from these mice and various controls (see below) were collected 6 d later and cultured
in anti-BDFI (groups A-F) and anti-B10.BR MLR cultures (groups A'-E'). Table entries are cytotoxic
activity (mean of six replicates t 1 SD) after 5 d of culture shown as a fraction of the untreated control.
In groups A and A', animals were injected with 1 .4 x 106, 1.6 x 106, 1 .9 x 106, or 2.0 x 106 recovered
labeled cells in Exps. 1-4, respectively. In control groups E and E', mice were injected with matching num-
bers of freshly collected BDFI LNC. Control group F is the response of LNC from a group of primary
recipient mice tested in the MLR cultures at the same time as the secondary recipients, i.e., 12 d after
injection of BDFI-FITC LNC.
In Exp. 3, 2 .5 x 107 cells were injected.
Flow cytometric analysis of the injected cells showed that 4-6 x 105 labeled cells were included in the in-
jected cell population.
conjugated BDFI LNC could be used to induce response reduction in a second B6
recipient and, if so, which cells. B6 mice were injected with 1.5 x 10' FITC-
conjugated BDFI LNG. 6 d later acell suspension was prepared from lymph nodes
and sorted into fluorescent and nonfluorescent fractions, wich were then injected
intravenously into other B6 mice. 6 d later LNC from these mice were tested for
their ability to respond against BDFI and third-party stimulators. Mice injected
with the fluorescent fraction (containing Fl cells that retained their label) showed
specific response reduction (Table I, group A); mice injected with the nonfluores-
cent fraction (containing host B6 cells and any injected F1 cells that may have lost
their label) showed anormal response(Table 1, groups B and C). All groups showed
anearnormal response againstthird-partyB10.BR stimulator cells(Table I, bottom
section).
Discussion
Ourexperimentsleadtothe conclusion that lymphoid cells taken from a parental
(B6) mouse injected 1-8 d previously with BDFI lymphoid cells, and subsequently
tested in an invitroMLR, havebeenfunctionally deleted ofCTLp capableofrecog-
nizing the injectedcellsbefore beingput inthe MLR (Fig. 7). This functionaldele-
tion appears toapply to the whole recirculatinglymphocyte pool (Fig. 5). It cannot
be reversed by addition ofan IL-2-containing supernatant, as equivalent reduction
Group Cells transferred 1
Experiment
2 3 4
A FITC-labeled (1 .4-2.0 x 106) 0.49 t 0.11 0.30 t 0.07 0.15 t 0.04 0.32 t 0.12
13' Unlabeled (2.0 x 107) 1.03 t 0.12 1 .14 t 0.11 0.67 t 0.11 1 .18 t 0.16
C Unlabeled (1.6 x 106) ND 1 .02 t 0.06 ND ND
DI Unsorted (2.0 x 107) 0.94 t 0.08 0.77 t 0.15 ND 0.54 t 0.10
E Fresh BDF1 (1 .4-2.0 x 106) 0.48 t 0.07 0.20 t 0.07 0.10 t 0.04 0.10 t 0.05
F Control: Donors for A to D 0.14 t 0.04 0.25 f 0.06 0.06 t 0.01 0.24 f 0.08
A' FITC-labeled (1 .4-2.0 x 106) 1 .01 f 0.09 0.76 t 0.11 ND ND
B" Unlabeled (2.0 x 107) 0.93 t 0.14 1 .18 t 0.16 ND ND
C' Unlabeled (1 .6 x 106) 0.92 t 0.15 0.76 t 0.14 ND ND
D' Unsorted (2.0 x 107) 0.81 t 0.12 0.82 t 0.14 ND ND
E' Fresh BDFI (1 .4-2.0 x 106) 0.98 t 0.08 0.85 t 0.16 ND ND686 HISTOINCOMPATIBLE LYMPHOCYTES IN CTL PRECURSOR DELETION
was seen in the limiting dilution assay measurements, where such a supernatant
was added (Fig. 7 b), and in bulk culture measurements or cytolytic activity, where
supernatant was not added (Fig. 7 a).
Several lines of evidence suggestthat functional deletion is not the result ofinduc-
tion in vivo of either host or donor antigen-specific (11) or antiidiotypic suppressor
cells (10) that act during the in vitro culture period. Thus, if there were suppressor
cells induced that acted in vitro, a mixture of lymph node cells prepared from pa-
rental controls and Fi-injected animals should produce a response less than the sum
of the separate responses. However, the frequency of CTLp activated in such a mix-
ture was equal to the sum of that observed in the separate populations (Fig. 7 b) .
Further evidence against a role for suppressor cells was obtained in cell sorting ex-
periments. Thus, when response reduction was induced by injectionof FITC-labeled
F1 cells, the same response reduction was observed in vitro whether or not labeled
F1 cells were removed before in vitro culture (Fig. 6). Here, suppressor cells, if
present, must either be F1 cells that have lost their label or host cells. However, if
instead of being put into MLR culture, the labeled and unlabeled fractions were
transferred into new recipients, only the labeled cells could induce response reduc-
tion in the new recipient (Table I). Thus, the labeled F1 cells retained the ability
to induce response reduction, perhaps, as discussed below, by producing a func-
tional deletion of host CTL precursors that recognize them.
It is important to note that these data do not rule out the possibility that sup-
pressor cells, of either host or donor origin, are induced at later times (i.e., later
than day 8) and we are currently investigating these possibilities.
Sano et al. (24) have shown that intravenouslyadministered allogeneic spleen cells,
previously treated with neuraminidase, canlead to reduction in the anti-allo-delayed-
type hypersensitivity (DTH)response, although untreated spleen cells have little effect.
They arguethat theneuraminidase-treated allogeneic donorcells concentrate in the
liver, subsequently attracting circulating reactive T cells involved in the DTH re-
sponse. Through an unknown mechanism, these events lead to long-term removal
of effector precursor cells from the circulation. In contrast, we found that injection
of neuraminidase-treated F1 LNC was less effective at inducing CTL response
reduction than an injection ofuntreated control Fi LNC (data not shown), and we
conclude that CTL precursor cells are not affected by the mechanism studied by
Sano et al. Note that DTH reactions primarily involve class II MHC, whereas CTL
reactions primarily involve class I MHC.
A veto cell is a cell that can inactivate CTLp that recognize it (17-20), and can
be thought of as a functionally deleting APC. The observations that we describe
here could be explained by this mechanism. Thus, donor Fi cells would containveto
cells that, when recognized by host CTLp reactive against the foreign alloantigen,
would lead to inactivation of these CTLp. Rammensee and colleagues have shown
tht intravenous injection of allogeneic, T cell-containinglymphoid cells leads to an
apparent functional deletion ofboth thehost and thedonorCTLp capable of recog-
nizing each other (6, 8). Our results generally confirm their findings and provide
additional evidence to show that the mechanism responsible for response reduction
is active in vivo, and is not due to induction of suppressor cells acting in vitro.
The veto phenomenon was first characterized by in vitro studies of the MLR,
where it was shown that certain cells (CTL, but also other cells) have the abilityMARTIN AND MILLER
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to produce functional deletion ofCTLp capableofrecognizing determinants on their
surface. It has been previously argued that a T cell that receives a specific signal
(i.e., antigen in association with MHC) but then fails to receive all the necessary
secondary signals will result in functional anergization of the T cell, rather than
activation (25). Consistent with this model, Jenkins et al. have recently shown that
peptidic antigenpresentedby APCs previously treatedwith thecrosslinking fixative
ECDI (26, 27), or by purified Ia incorporated into planar lipid membranes (28),
fails to activate class II-restricted, antigen-specific helper Tcell clones. Instead, this
encounter can induce long-termunresponsiveness ofthese Tcells to antigenpresented
subsequently by normal, untreated APC. The authorshave argued that the T helper
cell clones become unresponsive when a co-stimulatory factor fails to be delivered
concomitantly with the antigen-specific, MHC-restricted signal (as opposed to ac-
tive delivery ofsuppressor factors). Support for this has come from the observation
that addition of irradiated allogeneic B cells or macrophages to T cell clones cul-
tured with ECDI-treated APCs and antigen can lead to their activation rather than
anergization (27), putatively resultingfrom delivery ofaco-stimulatory factor. These
findings contrast with the in vitro veto phenomenon affecting CTLp, since it has
been observed that CTLp are most sensitive to veto 1-3 d after exposure to antigen
(29-31), and that mature CTL, (including CTL clones) are insensitive to inactiva-
tion by veto. Furthermore, theculture conditions used to detect activity ofveto cells
involve adding them to an MLR that includes irradiated allogeneic spleen cells as
stimulators. To this point, no analogous co-stimulatory signalshave been found that
can overcome the activity of veto cells, or restore the response of inactivated CTLp.
Themechanism offunctional deletion in the studieswe describedhere and in previous
in vitro studies (17-20) remains unclear and may not be the same in the two cases.
Although theprecisemolecularevents may be distinct, both classI-restricted CTLp
and class II-restricted helper T cells areapparently susceptible to functionally deleting
antigen presentation . Analogously, B lymphocytes may be made unresponsive sub-
sequent to interaction with specific antigenunderspecialconditions (32, 33). Deline-
ation of the mechanisms involved in functionally deleting antigenpresentation may
be essential to understanding the regulation of specific immunity.
It would appear that a veto-like phenomenon could readily explain the mecha-
nism of negative selection preventing the generation of autoreactive, pathogenic T
cells during ontogeny in the thymus (34-38). In addition, the evidence presented
in this paperraises the possibility that these mechanisms maypersist among mature
populations in the periphery of the adult animal. Since current evidence suggests
that processed self antigen may be presented on the cell surface in association with
MHC (39, 40), a peripheral veto mechanism increases the potential range of self
antigens that may be presented to persisting autoreactive T cells and hence does
not restrict the mechanism to privileged antigens presented solely in the thymic en-
vironment. It would then be intriguing to investigate the range ofantigens that could
be presented in a suppressive manner by such a system, the role of veto-like mecha-
nismsin the downregulation of an immune response, andhowsuch down regulating
systems avoid interfering with effective immunity to infectious agents. Conversely,
it would also be important to study if this system could be experimentally manipu-
lated in order to selectively control or delete undesireable specificities from the T
cell repertoire. This could be potentially useful for facilitating tissue allografting688 HISTOINCOMPATIBLE LYMPHOCYTES IN CTL PRECURSOR DELETION
or for inactivating pathogenic T cells responsible for certain autoimmune diseases.
Clinical precedent for this approach already exists, such as the observation that pa-
tients previouslytransfused with blood are more likely to accept a subsequent kidney
transplant (41). Animal studies indicate that this effect is optimized when the blood
transfusion and subsequent graft are matched at MHC (3). We and others (7, 20)
suggest that this might result from a veto mechanism similar to what we have dis-
cussed here.
Summary
It is well established that a single intravenous injection of Fl lymphocytes can rap-
idly and specifically reduce the ability of a parental recipient to generate CTL against
donor alloantigens in a subsequent MLR. By fluorescently labeling the injected cells,
we have been able to identify, and if desired, remove them in cell suspensions pre-
pared from recipient spleen and lymph node. The injected cells, whether F1 or syn-
geneic, appeared to form part of the normal recirculating pool. Removal ofinjected
Fl cells from responder lymph node or spleen cell suspensions had no effect on the
response reduction observed in the 5-d in vitro MLR (typically 80% reduction for
responder cells taken 2 d after injection of Fi cells). When the frequency of CTL
precursors (CTLp) was measured by limiting dilution, it was reduced to the same
degree as the MLR response, implying that response reduction is due to a reduction
in the number of activatable CTL in the responder cell suspension. An equal mix-
ture of responder cells from treated (i.e., Fl injected) and control mice gave a mea-
sured CTLp frequency equivalent to the average of the separate frequencies, im-
plying the absence of suppressor cells active in vitro. Labeled Fl cells recovered from
a first recipient could be used to induce response reduction in a second recipient.
The results are discussed in terms ofAPCs that functionally delete rather than stimulate
CTLp that recognize them (i.e., a "veto mechanism"). These experiments appear
to rule out a role for in vivo-induced suppressor cells up to 8 d after injection of
semiallogeneic cells but do not address the question of whether they are induced
at later times.
We thank Juliet Sheldon and Rosemary Weersink for help with the flow cytometry.
Receivedforpublication 7November 1988 and in revisedform 17 March 1989.
References
1 . Wilson, D. B., and P. C . Nowell. 1971. Quantitative studies on the mixed lymphocyte
interaction in rats. Tempo and specificity of the proliferative response and the number
of reactive cells from immunized donors. J Exp. Med. 133 :442.
2 . Miller, R. G., and R. A. Phillips. 1976. Reduction of the in vitro cytotoxic lymphocyte
response produced by in vivo exposure to semiallogeneic cells: recruitment or active sup-
pression? J. Immunol. 117:1913.
3 . Faustman, D., P Lacy, J . Davie, and V. Hauptfeld. 1982. Prevention of allograft rejec-
tion by immunization with donor blooddepleted of la-bearing cells. Science(Wash. DC).
217:157.
4. Good, M. F., and G. J. V. Nossal. 1983. Functional clonal deletion and suppression as
complimentary mechanisms operative in adult hapten-induced cytotoxic T cell toler-
ance. J. Immunol. 131:2662 .MARTIN AND MILLER
￿
689
5. Fink, P J., I. L. Weissman, and M. J. Bevan. 1983. Haplotype-specific suppression of
cytotoxic T cell induction by antigen inappropriately presented on T cells. J. Exp. Med.
157:141.
6. Rammensee, H. G., P. J. Fink, and M. J. Bevan. 1984. Functional clonal deletion of
class I-specific cytotoxic T lymphocytes by veto cells that express antigen. J. Immunol.
133:2390.
7. Ishikawa, H., T Hino, H. Kato, H. Suzuki, and K. Saito. 1986. Cytotoxic T lymphocyte
response to minor H-42a alloantigen in H-426 mice: Clonal inactivation ofthe precursor
cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen. J. Im-
munol. 137 :2080.
8. Rammensee, H. G., and M. J. Bevan. 1987. Mutual tolerization of histoincompatible
lymphocytes. Eur. J. Immunol. 17:893 .
9. Madsen, J. C., R. A. Superina, K. J. Wood, and K. F. Morris. 1988. Immunological
unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature
(Loud.). 332:161.
10. Kimura, H., and D. B. Wilson. 1984. Anti-idotypic cytotoxic T cells in rats with graft-
versus-host disease. Nature (Loud.). 308:463.
11 . Dorsch, S., and B. Roser. 1982 . II. Identification and probable mode of action of chi-
meric suppressor T cells. Transplantation (Baltimore). 33:525.
12. Sopori, M. L., R. S. Perrone, S. Cherian, R. J . Cross, and A. M. Kaplan. 1985. Immu-
noregulation in the rat: Characteristics of a suppressor T cell that inhibits antigen-
dependent cell proliferation. J. Immunol. 135:80.
13. Malkovsky, M ., G. L. Asherson, B. Stockinger, and M. C. Watkins. 1982. Nonspecific
inhibitor released by T receptor cells reduces the production ofinterleukin-2. Nature (Load.).
300:652.
14. Heslop, B. F., and B. E. Hardy. 1971. The distribution of "Cr-labeled syngeneic and
allogeneic lymph node cells in the rat. Transplantation (Baltimore). 11:128.
15. Sprent, J., J. F A. P Miller, and G. F Mitchell. 1971. Antigen-inducedselective recruit-
ment of circulating lymphocytes. Cell. Immunol. 2:171.
16. Emeson, E. E., and D. R. Thursh. 1974. Antigen-induced trapping of immunospecific
lymphocytes in the spleen. J. Immunol. 113 :1575.
17. Miller, R. G. 1980. Strategies ofImmune Regulation. E. E. Sercarz and A. J. Cunning-
ham, editors. Academic Press, New York. 507-512.
18 . Miller, R. G. 1980. An immunological suppressor cell inactivating cytotoxic T lympho-
cyte precursor cells recognizing it. Nature (Loud.). 287:544.
19 . Miller, R. G. 1986. The veto phenomenon and T cell regulation. Immunol. Today. 7:112.
20 . Fink, P J., R. P Shimenkovitz, and M. J. Bevan. 1988. Veto cells. Annu. Rev. Immunol. 6:115.
21 . Butcher, E. C ., and I. L. Weissman. 1980. Direct fluorescent labeling ofcells with fluores-
cein or rhodamine isothiocyanate. I. Technical aspects. J. Immunol. Methods. 37 :97.
22 . Butcher, E. C., R. G. Scollay, and I. L. Weissman. 1980. Direct fluorescent labeling of
cells with fluorescein or rhodamine isothiocyanate. II. Potential application to studies
of lymphocyte migration and maturation. J Immunol. Methods. 37:109.
23 . Miller, R. G. 1982. Clonal analysis by limiting dilution. An overview. In Isolation,Char-
acterization, and Utilization of T Lymphocyte Clones. C. G. Fathman and F W. Fitch,
editors. Academic Press, New York. 220-233.
24 . Sano, S., T. Soda,J.-H. Qian, S. Sato, R. Ikegami, T. Hamaoka, and H. Fujiwara. 1987 .
Abrogation ofthe delayed-type hypersensitivity responses to alloantigens by intravenous
injection of neuraminidase-treated allogeneic cells. J Immunol. 139:3652.
25. Malkovsky, M., and P B. Medawar. 1984. Is immunological tolerance (non-responsiveness)
a consequence ofinterleukin 2 deficit during the recognition of antigen? Immunol. Today.
5 :340.
26. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified690 HISTOINCOMPATIBLE LYMPHOCYTES IN CTL PRECURSOR DELETION
splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp.
Med. 168:302.
27 . Jenkins, M. K.,J. D. Ashwell, and R. H. Schwartz. 1988. Allogeneic nonT spleen cells
restore the responsiveness of normal T cell clones stimulated with antigen and chemi-
cally modified antigen-presenting cells. J . Immunol. 140:3324.
28. Quill, H., and R. H. Schwartz. 1987. Stimulation of normal inducer T cell clones with
antigen presented by purified la molecules in planar lipidmembranes: specific induction
of a long-lived state of proliferative nonresponsiveness. J . Immunol. 138:3704.
29. Claesson, M. H., and R. G. Miller. 1984. Functional heterogeneity in allospecific cyto-
toxic T lymphocytes clones. I. CTL clones express strong anti-self suppressive activity.
J . Exp. Med. 160:1702.
30. Muraoka, S., D. L. Ehman, and R. G. Miller. 1984. Irreversible inactivation ofactivated
cytotoxic T lymphocyte precursor cells by "anti-self" suppressor cells present in murine
bone marrow T cell colonies. Eur. J Immunol. 14:1010.
31 . Fink, P. J ., H.-G. Rammensee, J. D. Benedetto, U. D. Staerz, L. Lefrancois, and
M. J. Bevan. 1984. Studies on the mechanism of suppression of primary cytotoxic re-
sponses by cloned cytotoxic T lymphocytes. J. Immunol. 133:1769.
32. Nossal, G. J. V 1983. Cellular mechanisms of immunologic tolerance. Annu. Rev. Im-
munol. 1:33.
33. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J . Smith-Gill, R. A. Brink,
H . Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, R. N. Trent, and
A. Basten. 1988. Altered immunoglobulin expression and functional silencing of self-
reactive B lymphocytes in transgenic mice. Nature (Loud.). 34:676.
34 . Kilielow, P., H. Bluthmann, U. D. Staerz, M. Steinmetz, and H. von Boehmer. 1988.
Tolerance in Tcell-receptor transgenic mice involves deletion of nonmature CD4'8'
thymoeytes. Nature (Lond). 333 :742.
35 . Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H . Russell, and D. Y. Loh.
1988. Selective expression ofan antigen receptor on CD8-bearing T lymphocytes in trans-
genic mice. Nature (Loud.). 335:271.
36. Marrack, P., D. Lo, R. Brinster, R. Palmiter, L. Burkly, R. G. Flavell, and J. Kappler.
1988. The effect ofthymus environment on T cell development and tolerance. Cell. 53:627 .
37 . Kappler, J. W., U. Staerz,J. White, and P. C . Marrack. 1988. Self-tolerance eliminated
T cells specific for Mls-modified products ofthe major histocompatibility complex. Na-
ture (Lond.). 332:35.
38. MacDonald, H . R., R. Schneider, R. K. Lees, R. C. Howe, H. Acha-Orbea, H. Festen-
stein, R. M. Zinkernagel, and H. Hengartner. 1988. Tcell receptor V use predicts reac-
tivity and tolerance to Mlsa-encoded antigens. Nature (Lond). 332 :40.
39. Matzinger, P, and M . J. Bevan. 1977. Hypothesis why so many lymphocytes respond
to major histocompatibility antigens. Cell. Immunol. 29:1.
40. Bjorkman, P J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and
D. C. Wiley. 1987. Structure of the human class I histocompatibility antigen, HLA-A2.
Nature (Lond). 329:506.
41 . Opelz, G., M. R. Mickey, and P. I . Terasaki. 1981. Blood transfusions and kidney trans-
plants: Remaining controversies. Transplant. Proc. 13:136.